the management of itp during and after the covid-19 pandemic
Published 1 year ago • 335 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
4:20
itp update: diagnosis, treatment & covid-19 vaccines
-
2:31
management of all patients during covid-19
-
0:52
insights from advance iv study: efgartigimod increases platelet counts of patients with itp
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
3:23
session overview: improving treatment for patients with itp
-
1:24
recent advances in the treatment and management of itp
-
1:06:04
itp: novel treatments
-
4:41
a 12-year-old app developer | thomas suarez | ted
-
45:50
treating persistent/chronic itp current care, future potential
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
2:06
current unmet needs in itp: impaired quality of life & chronic disorders
-
1:59
novel investigational drugs and promising therapies for immune thrombocytopenia
-
1:51
checkpoint inhibition in the treatment of mpns
-
2:03
unmet needs in immune thrombocytopenia
-
0:30
safety & efficacy of tpo-ras in elderly patients with itp
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
2:07
thromboprophylaxis in patients with vwd and covid-19
-
4:48
an insight into the management of cytopenias in mf